Image For Activity Cover
Dapagliflozin in Patients With Heart Failure and Deterioration in Renal Function (JACC November 2023-1)
SGLT-2 inhibitors are guideline-recommended in the management of heart failure (HF). While these therapies can be initiated even in patients with comorbid CKD, some patients may face deterioration in kidney function over time. 

Valentin Fuster, MD, PhD, MACC

CME Editor
Ragavendra R. Baliga, MD

Yevgeniy Khariton, MD, FACC 

Important Dates
Date of Release: October 30, 2023

Term of Approval/Date of CME/MOC Expiration: October 29, 2024
Availability: On-Demand
Expires on Oct 29, 2024
Cost: FREE
Credit Offered:
1 CME Credit
1 ABIM-MOC Point
Android App Download IOS App Download Powered By